CEO Dr Leearne Hinch said, “Our EXO-OC test addresses a critical unmet need for early detection of ovarian cancer. INOVIQ is now positioned as a global leader in exosome technology, offering best-in-class exosome isolation and diagnostic solutions that can transform precision oncology." …
Australian innovation could revolutionise the early detection of ovarian cancer
June 2, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 13, 2025 - - Latest News -
New immunisation strategy highlights COVID impact, priority patients and new technologies
June 12, 2025 - - Latest News -
Medicines Australia establishes radiopharmaceuticals working group
June 12, 2025 - - Latest News -
MSD Australia and New Zealand certified a 'Great Place to Work'
June 12, 2025 - - Latest News -
Specialised Therapeutics expands partnership with Incyte to include two additional therapies
June 12, 2025 - - Latest News -
Novo Nordisk partners with Heart of Australia to expand clinical trial access
June 12, 2025 - - Latest News -
Mark Butler starts the process of NDIS pricing reform
June 11, 2025 - - Latest News